Adicet Bio, Inc. — Director's Dealing 2022

Feb 14, 2022

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2021-12-31

Reporting Person: Jakobovits Aya (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-22	Common Stock	S	7000	$16.0162	Disposed	332552	Indirect
2021-12-22	Common Stock	S	7000	$16.0286	Disposed	332553	Indirect
2021-12-23	Common Stock	G	109488	$0.00	Disposed	0	Indirect
2021-12-23	Common Stock	G	29905	$0.00	Acquired	138076	Indirect
2021-12-23	Common Stock	G	39791	$0.00	Acquired	372343	Indirect
2021-12-23	Common Stock	G	39792	$0.00	Acquired	372345	Indirect

Footnotes

F1: These sales were effected pursuant to Rule 10b5-1 trading plans previously adopted by the Reporting Person.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.46 to $16.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3: Shares held in a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' daughter is the beneficiary.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.47 to $16.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F5: Shares held in a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' son is the beneficiary.

F6: Represents a gift of Common Stock made on December 23, 2021.

F7: Shares transferred from a grantor retained annuity trust ("GRAT") of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits the sole annuitant and current beneficiary. Following this transaction, this GRAT was terminated.

F8: Shares held in a revocable trust of which Dr. Jakobovits and her spouse are co-trustees.